Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters 5 - Best Posters in comorbidities in heart failure Cardiotoxicity of drugs ESC Premium Access ESC Congress 2017

ESC 365 is supported by

ESC 365 is supported by